Author Archives: Steve Bryson PhD

Oral On-demand KVD900 Rapidly Reduces HAE Attack Severity

KVD900, an oral experimental on-demand treatment for swelling episodes caused by hereditary angioedema (HAE), safely and significantly reduced the severity of attacks and shorted the time to improvement, which was maintained for 24 hours, according to Phase 2 trial data.  “Our goal is to provide the best outcome…